Evaluating the Cost-effectiveness of Pharmaceuticals in Canada
Canada adopted guidelines for the economic evaluation of pharmaceuticals in 1994, and a central process for drug assessment in 2003. The context and the way the issue reached the agenda in the two time periods differed. The guidelines were adopted amidst growing academic interest in methods for eco...
Main Author: | Katherine Boothe |
---|---|
Format: | Article |
Language: | English |
Published: |
McMaster University Library Press
2016-03-01
|
Series: | Health Reform Observer - Observatoire des Réformes de Santé |
Subjects: | |
Online Access: | https://mulpress.mcmaster.ca/hro-ors/article/view/2796 |
Similar Items
-
Evaluating the Cost-effectiveness of Pharmaceuticals in Canada
by: Katherine Boothe
Published: (2016-03-01) -
Managing Pharmaceutical Costs in Health Systems: A Review of Affordability, Accessibility and Sustainability Strategies
by: Christos Ntais, et al.
Published: (2024-12-01) -
Cost-consequence analysis of Pharmaceutical Care program for systemic arterial hypertension in the public health system in Brazil
by: Maurílio de Souza Cazarim, et al.
Published: (2018-02-01) -
Healthcare failure mode and effects analysis and cost‑minimization analysis of three pharmaceutical services
by: Álvaro Caballero-Romero, et al.
Published: (2021-03-01) -
Cost effectiveness of using trastuzumab biosimilars compared to trastuzumab original drugs to treat breast cancer in a hospital setting
by: Eric C. Barat, et al.
Published: (2023-12-01)